Zhan P - Search Results

1

Curcumin upregulates the Nrf2 system by repressing inflammatory signaling-mediated Keap1 expression in insulin-resistant conditions.

Ren L, Zhan P, Wang Q, Wang C, Liu Y, Yu Z, Zhang S. Ren L, et al. Among authors: zhan p. Biochem Biophys Res Commun. 2019 Jun 30;514(3):691-698. doi: 10.1016/j.bbrc.2019.05.010. Epub 2019 May 9. Biochem Biophys Res Commun. 2019. PMID: 31078267

2

Metformin exerts glucose-lowering action in high-fat fed mice via attenuating endotoxemia and enhancing insulin signaling.

Zhou ZY, Ren LW, Zhan P, Yang HY, Chai DD, Yu ZW. Zhou ZY, et al. Among authors: zhan p. Acta Pharmacol Sin. 2016 Aug;37(8):1063-75. doi: 10.1038/aps.2016.21. Epub 2016 May 16. Acta Pharmacol Sin. 2016. PMID: 27180982 Free PMC article.

3

Topotecan alleviates ventilator-induced lung injury via NF-κB pathway inhibition.

Wan B, Xu WJ, Zhan P, Jin JJ, Xi GM, Chen MZ, Hu YB, Zhu SH, Liu HB, Wang XX, Zhang XW, Lv TF, Song Y. Wan B, et al. Among authors: zhan p. Cytokine. 2018 Oct;110:381-388. doi: 10.1016/j.cyto.2018.04.016. Epub 2018 May 24. Cytokine. 2018. PMID: 29803659

4

Deubiquitinase PSMD14 enhances hepatocellular carcinoma growth and metastasis by stabilizing GRB2.

Lv J, Zhang S, Wu H, Lu J, Lu Y, Wang F, Zhao W, Zhan P, Lu J, Fang Q, Xie C, Yin Z. Lv J, et al. Among authors: zhan p. Cancer Lett. 2020 Jan 28;469:22-34. doi: 10.1016/j.canlet.2019.10.025. Epub 2019 Oct 18. Cancer Lett. 2020. PMID: 31634528

5

IGFBP3 A-202C polymorphism and breast cancer susceptibility: a meta-analysis involving 33,557 cases and 45,254 controls.

Qiu LX, Yao L, Yuan H, Mao C, Chen B, Zhan P, Xue K, Zhang J, Hu XC. Qiu LX, et al. Among authors: zhan p. Breast Cancer Res Treat. 2010 Aug;122(3):867-71. doi: 10.1007/s10549-010-0739-9. Epub 2010 Jan 19. Breast Cancer Res Treat. 2010. PMID: 20084546

6

Prognostic value of vascular endothelial growth factor expression in patients with lung cancer: a systematic review with meta-analysis.

Zhan P, Wang J, Lv XJ, Wang Q, Qiu LX, Lin XQ, Yu LK, Song Y. Zhan P, et al. J Thorac Oncol. 2009 Sep;4(9):1094-103. doi: 10.1097/JTO.0b013e3181a97e31. J Thorac Oncol. 2009. PMID: 19687765 Free article. Review.

7

[Management and differential diagnosis of Ground-Glass Opacity pulmonary lesions.].

Song Y, Zhan P. Song Y, et al. Among authors: zhan p. Zhonghua Jie He He Hu Xi Za Zhi. 2009 Nov;32(11):808-9. Zhonghua Jie He He Hu Xi Za Zhi. 2009. PMID: 20079289 Chinese. No abstract available.

8

Predictive value of ERCC1 and XPD polymorphism in patients with advanced non-small cell lung cancer receiving platinum-based chemotherapy: a systematic review and meta-analysis.

Wei SZ, Zhan P, Shi MQ, Shi Y, Qian Q, Yu LK, Song Y. Wei SZ, et al. Among authors: zhan p. Med Oncol. 2011 Mar;28(1):315-21. doi: 10.1007/s12032-010-9443-1. Epub 2010 Feb 9. Med Oncol. 2011. PMID: 20143185 Review.

9

The role of matrix metalloproteinase 2 on the survival of patients with non-small cell lung cancer: a systematic review with meta-analysis.

Qian Q, Wang Q, Zhan P, Peng L, Wei SZ, Shi Y, Song Y. Qian Q, et al. Among authors: zhan p. Cancer Invest. 2010 Jul;28(6):661-9. doi: 10.3109/07357901003735634. Cancer Invest. 2010. PMID: 20394501 Review.

10

ERCC2/XPD Lys751Gln and Asp312Asn gene polymorphism and lung cancer risk: a meta-analysis involving 22 case-control studies.

Zhan P, Wang Q, Wei SZ, Wang J, Qian Q, Yu LK, Song Y. Zhan P, et al. J Thorac Oncol. 2010 Sep;5(9):1337-45. doi: 10.1097/JTO.0b013e3181e7fe2a. J Thorac Oncol. 2010. PMID: 20651612 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

983 results

Search Page

Filters